학술논문

Analyzing the Difference in the Length of Stay (LOS) in Moderate to Severe COVID-19 Patients Receiving Hydroxychloroquine or Favipiravir
Document Type
Article
Source
In: Pharmaceuticals. (Pharmaceuticals, December 2022, 15(12))
Subject
Language
English
ISSN
14248247